Dynamis Pharmaceuticals
Jenkintown · Founded 1997
About Dynamis Pharmaceuticals
Dynamis Pharmaceuticals, Inc. is a biopharma company that is developing proprietary small molecule drugs to treat chronic inflammatory diseases. Its proprietary drug candidates inhibit a novel enzymatic pathway that causes the formation of a highly reactive sugar, 3-deoxyglucosone, that stimulates the production of Advanced Glycation End Products (AGEs), oxidative stress and a cascade of inflammatory cytokines.
Company Facts
- Founded: 1997
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Funding stage: Seed
- Last round: Seed (Jan 2004)
- Website: dynamis-therapeutics.com
- Phone: (215)376-5290
Social Profiles
Canonical: https://fsome.com/organization/dynamis-pharmaceuticals-8362754 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.